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Abstract
When a randomized controlled trial is not feasible, a key strategy in observational studies
is to ensure that intervention and control groups are comparable on observed characteristics
and assume that the remaining unmeasured characteristics will not bias the results. In the
past few years, propensity score-based techniques such as matching, stratification and
weighting have become increasingly popular for evaluating health care interventions.
Recently, marginal mean weighting through stratification (MMWS) has been introduced as
a flexible pre-processing approach that combines the salient features of propensity score
stratification and weighting to remove imbalances of pre-intervention characteristics
between two or more groups under study. The weight is then used within the appropriate
outcome model to provide unbiased estimates of treatment effects. In this paper, the
MMWS technique is introduced by illustrating its implementation in three typical experi-
mental conditions: a binary treatment (treatment versus control), an ordinal level treatment
(varying doses) and nominal treatments (multiple independent arms). These methods are
demonstrated in the context of health care evaluations by examining the pre-post difference
in hospitalizations following the implementation of a disease management program for
patients with congestive heart failure. Because of the flexibility and wide application of
MMWS, it should be considered as an alternative procedure for use with observational data
to evaluate the effectiveness of health care interventions.
Introduction
Conducting a randomized controlled trial (RCT) to evaluate the
effectiveness of health-related programs and other interventions is
often not feasible due to logistical, practical or ethical reasons. In
such situations, program evaluators attempt to emulate the
randomization process in observational data by ensuring that all
groups under study are comparable on observed pre-intervention
characteristics. However, unlike in an RCT, an assumption is
required that unmeasured characteristics do not bias the results [1].
When pre-intervention differences between groups are found, con-
ventional regression modeling remains the most common adjust-
ment approach, even though there is sufficient evidence that these
methods may produce biased results [2,3].
In recent years, adjustment techniques based on the propensity
score have become increasingly popular in health care evaluations
[4–7]. The propensity score reflects the probability of assignment
to the treatment group conditional on observed covariates [8].
Propensity scores are generally derived from a logistic regression
model that reduces each participant’s set of covariates to a single
score. Conditional on a well-constructed propensity score, pre-
treatment covariates will be independent of group assignment and
will be distributed similarly across study groups. When correlation
of covariates and treatment assignment is removed, the covariates
will not confound estimated treatment effects [8]. Once the pro-
pensity score has been estimated in a given dataset, a data ‘pre-
processing’ procedure is performed to create comparability
between study groups and typically involves matching, stratifica-
tion or weighting. It is referred to as pre-processing because it is
performed before the final treatment effect is estimated, thus rep-
licating the RCT by separating the study design stage from the
outcomes analysis [5].
There are several different matching algorithms currently in use
to match treated to non-treated individuals on their propensity
score, such as pairwise matching (also called one-to-one match-
ing), 1:k matching [9], matching using propensity score categories
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[10], matching based on the Mahalanobis distance [11] and kernel
density matching [12] (see Caliendo & Kopeinig [13] for a com-
prehensive discussion on propensity score matching).
Stratification (also referred to as subclassification) is another
propensity score adjustment approach. Here, the entire range of
propensity scores in the dataset is divided into strata (by partition-
ing the propensity score into a number of quantiles), and then
treated and non-treated groups are arranged within each stratum
accordingly. This approach allows the evaluator to analyse out-
comes between groups within each stratum as well as to observe
overall differences between groups across all strata [14]. It has
been shown that stratification of the propensity score into five
quantiles can remove over 90% of the initial bias due to the
covariates used to create the propensity score [15,16].
Another propensity score-based adjustment procedure involves
weighting each individual in the data, conditional on both their
propensity score and treatment group assignment. The most com-
monly used weighting scheme is the inverse probability of treat-
ment weights (IPTW) [3,17], which is intended to standardize the
treatment groups to the population for which treatment is intended.
Participants receive a weight equal to the inverse of the estimated
propensity score (1/propensity score) and non-participants receive
a weight equal to the inverse of 1 minus the estimated propensity
score (1/(1 – propensity score)). Once the weights are constructed,
they can then be used within the appropriate regression model
framework. A recent extension of the IPTW approach is the
‘doubly robust’ estimator [18,19], which utilizes IPTW and
covariates within the same outcome model. An estimator is con-
sidered doubly robust as long as either model (propensity score or
outcomes) is correctly specified. Therefore, an evaluator is given
two chances, instead of only one, to make a valid inference about
the effects of the treatment.
Recently, an approach has been introduced that combines
elements of both propensity score stratification and IPTW [20–
22]. In general, this first entails stratifying the analytic sample
into quantiles of the propensity score, and then generating a
weight for each individual based on their corresponding stratum
and treatment assignment. The stratification reduces bias in the
observed covariates used to create the propensity score, and
the weighting standardizes each treatment group to the target
population.
This approach, named ‘marginal mean weighting through strati-
fication’ (MMWS) [21,22], can handle a broad array of experi-
mental conditions that researchers will likely encounter in
evaluating health care interventions such as: binary treatments
(one treatment and one control group), ordinal treatments (various
dose levels of a treatment) and nominal treatments (multiple inde-
pendent treatments). Once generated, the MMWS can then be used
within the appropriate outcome model to estimate unbiased treat-
ment effects.
This paper introduces MMWS as an alternative propensity
score-based approach for providing unbiased treatment effect esti-
mates in non-randomized health care interventions. Its application
is illustrated using data from a disease management (DM) program
for patients with congestive heart failure. The paper begins by
describing the dataset and is followed by a detailed explanation of
the analytic procedure for binary, ordinal and nominal treatments
applied to the current data. The final section discusses the strengths
and weaknesses of the MMWS.
Data
Our data come from a DM program designed for patients with
congestive heart failure and implemented in a large health plan
located in the Western United States. Individuals with the condi-
tion were called and invited to enrol in the program. Those agree-
ing to participate received one of the following interventions based
on the subjective assignment by a program nurse: (1) periodic
telephone calls from a nurse to discuss self-management behav-
iours; or (2) remote tele-monitoring (RTM) that entailed daily
electronic transmission of the participant’s disease-related symp-
toms to a database followed by a call from the nurse if symptoms
appeared to indicate the onset of an acute exacerbation. The
primary goal of the intervention was to reduce avoidable hospi-
talizations [23]. We use these data solely to illustrate the MMWS
techniques, and our analyses do not represent a definitive assess-
ment of the program’s effectiveness. These data were chosen
because the intervention can be examined in various ways – as a
binary treatment (participants versus non-participants), as an
ordinal treatment (varying doses of the telephonic intervention) or
as a nominal treatment (comparison between telephonic and RTM
interventions).
The retrospectively collected data consist of observations for
1359 program participants who completed a full 12 months of the
intervention and 6612 non-participants who were health plan
members during the same period but were not exposed to the
intervention. Each individual in the dataset has 12 months of
pre-intervention data and 12 months of intervention-period data.
The primary outcome for all analyses used in this paper is the
difference between pre-intervention and intervention-period all-
cause hospitalization rates. All analyses were conducted using a
software program written by the author for Stata (StataCorp.,
College Station, TX, USA), which is available upon request.
Application of MMWS to
a binary treatment
A binary treatment (in which a treatment group is compared with
a control group), is the most prevalent study design in health care.
In this framework, a well-matched control group serves as the
counterfactual to the treatment group, that is, it provides an esti-
mate of what the treatment group’s outcome would have been had
it simultaneously not received the treatment. Here, we compare all
1359 program participants to all 6612 non-participants.
Supporting Information Appendix S1 describes the pre-
intervention characteristics of the DM program participant and
non-participant groups together with their unadjusted standardized
differences [24] and P-values (presented as measures of covariate
balance between groups). If the groups were comparable, stand-
ardized differences would be close to zero and P-values would be
non-significant (>0.05). However, there are several observed base-
line variables that are imbalanced (standard differences >0.10 or
P-values < 0.05), indicating the need to adjust for selection bias.
The first step in implementing MMWS is to estimate the pro-
pensity score using logistic regression and save the predicted
values for each individual. Here, the binary treatment variable was
regressed on all variables presented in Supporting Information
Appendix S1, including patient demographic characteristics (age
and gender), the Charlson comorbidity index and associated
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comorbidities [25], and key measures of health care utilization
(prescription filled, office visits, emergency department visits, hos-
pital admissions and hospital days).
Next, the region of common support was identified and individ-
uals outside of this region were flagged. Common support simply
means that treated individuals have a corresponding
counterfactual. Most commonly, treated individuals at the high end
of the propensity score distribution may not have non-treated indi-
viduals with corresponding propensity scores, and vice versa.
Treatment effect estimates will be biased if individuals do not have
counterfactuals as a point of comparison. In the MMWS frame-
work, individuals outside the region of common support receive a
weight of zero [22]. In our data, five individuals (all from the
control group) were outside the region of support and received
weights of zero.
Next, propensity scores for all individuals were stratified into
five approximately equal-sized quintiles of 1593 individuals per
stratum (see Table 1), as recommended by Rosenbaum & Rubin
[16].
Finally, the marginal mean weights for the binary treatment
were computed based on the following equation by Hong [22]:
n Z z
n
s
z z s
× =
=
Pr( )
,
(1)
where ns is the total number of individuals in a given stratum s,
Pr(Z = z) is the probability of assignment to treatment group z, and
nz=z,s is the total number of individuals in stratum s that were
actually assigned to treatment z. Table 1 displays all the values
needed to compute the MMWS for each stratum by group assign-
ment. Using the treatment group in stratum 1 as an example, we
replace Equation 1 with the numeric equivalents:
1594 1359
7966
121
2 247
× ⎛⎝ )
= .
Similarly, the MMWS weights for the control group in stratum 1
are calculated as follows:
1594 6607
7966
1473
0 898
× ⎛⎝ )
= .
After weights were calculated for each treatment group by stratum,
each individual in the dataset received the weight corresponding to
their stratum and treatment assignment.
Supporting Information Appendix S2 presents the baseline
characteristics of the treatment and control groups adjusted with
the MMWS weights. As shown, all baseline covariates now have
standardized differences closer to zero than when unweighted, and
all P-values are substantially higher than the traditional 0.05 cut-
off. This lends greater confidence that the weighting approach has
controlled for observed confounding that may bias the treatment
effect estimates.
Supporting Information Appendix S3 provides a comparison of
the unweighted and weighted treatment effect estimates for the
differences in pre-to-post hospitalization rates. In the unweighted
data, the treatment group experienced a reduction in pre-post
admissions of −0.20 admission per person while the control group
had a substantially larger reduction in pre-post admission of −0.33
per person. The net difference of 0.13 in favour of the control
group was statistically significant (P < 0.0001). After adjustment
using MMWS, the control group still had a favourable difference
in pre-post admissions versus the treatment group, but the differ-
ence was no longer statistically significant (difference in differ-
ences = 0.08, P-value = 0.056, 95% CI: −0.002, 0.165).
Application of MMWS to
ordinal treatments
Interventions that include varying doses of an ordinal level treat-
ment are also pervasive in health care. Examples include drug
studies in which different dosages of a medication are compared
and health interventions that involve multiple contacts with a
health professional. In these cases, the evaluation seeks to assess
whether there is a positive (or inverse) relationship between dose
and the outcome.
In the multi-dose framework, the comparison group may be
either a control group that receives no intervention or the group
that receives the lowest treatment dose (in studies where all par-
ticipants receive at least some level of the intervention). In an
observational study, weighting techniques can serve to achieve
balance on baseline characteristics between all treatment levels. In
the outcomes analysis, either the control group or the lowest dose
group (in those studies in which everyone is exposed to some level
of the intervention) serves as the counterfactual for the treatment
groups at higher dosages.
In the current data, there were 654 participants in the 12-month
telephonic intervention. For the purpose of illustrating the MMWS
technique, the sample is divided into four distinct groups based on
the observed distribution of the call frequency: (1) non-
participants; (2) participants who received only one call; (3) par-
ticipants who received two or three calls; and (4) participants who
received four or more calls over the 12-month intervention period.
Group 1 serves as the control and is comprised of non-participants
who never received any calls.
Table 1 Calculation of the marginal mean
weights through stratification (MMWS) for
a binary treatment within common support
Stratum
Treated
(nz=1,s)
MMWS
(treated)
Non-treated
(nz=0,s)
MMWS
(non-treated) ns
1 121 2.247 1473 0.898 1594
2 196 1.387 1397 0.946 1593
3 236 1.152 1357 0.974 1593
4 355 0.766 1238 1.067 1593
5 451 0.603 1142 1.157 1593
Total 1,359 6607 7966
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Supporting Information Appendix S4 describes the unadjusted
pre-intervention characteristics of participants in the three dose
levels of the intervention and the non-participant group. As shown,
groups were statistically different from each other in 7 of the 11
covariates – once again indicating the need to adjust for selection
bias.
For an intervention with ordinal level treatments, the propensity
score can be estimated via ordinal logistic regression [26]. Ordinal
regression assumes that the proportional odds of being assigned to
any given treatment level are the same as any other treatment level,
given the covariates used for estimation (this is referred to as the
parallel regression assumption). If this assumption holds, any pre-
dicted level of treatment may serve as the basis for calculating the
propensity score. In the current data, the ordinal treatment variable
was regressed on all covariates described earlier in the binary
treatment section. Following the recommendation of Lu et al. [27],
the propensity score was estimated to reflect the probability of
being assigned to the lowest treatment dose (non-participation
group).
As in the case of the binary treatment, the region of common
support was established by ensuring that no individual in any
group exceeded the lower or upper common propensity score
threshold of any other treatment level. All individuals outside of
this common region were flagged and received an MMWS weight
of zero. In the current data, a total of 439 individuals were flagged
as being outside the region of support, leaving a total of 6827
individuals for the analytic sample (see Table 2).
Next, propensity scores for everyone in the analytic sample
were stratified into five approximately equal-sized quintiles of
1365 individuals per stratum and the marginal mean weights were
computed based on the same formula as presented in Equation 1.
Table 2 displays all the necessary values used in computing the
MMWS for each stratum and treatment assignment. Using the
non-treatment group in stratum 1 as an example, we replace Equa-
tion 1 with the numeric equivalents:
1366 6185
6827
1181
1 048
× ⎛⎝ )
= .
Similarly, the MMWS weights for the group receiving four or
more calls during the intervention year in stratum 2 are calculated
as follows:
1365 115
6827
30
0 766
× ⎛⎝ )
= .
After weights were calculated for each treatment group by stratum,
each individual in the dataset received the weight corresponding to
their stratum and treatment assignment.
Supporting Information Appendix S5 presents the baseline
characteristics of the participants in the three dose levels of the
intervention compared with the non-participant group adjusted
using MMWS weights. As there is no equivalent to the standard-
ized difference metric for multiple treatments, researchers mostly
rely on P-values as the numeric measure of covariate balance, with
the statistical expectation being that up to 5% of the covariates
analysed will be statistically significant due to chance alone. As
shown, with the exception of age, all covariates in the weighted
data have P-values that are substantially higher than the traditional
0.05 cut-off. The residual imbalance of age will be further adjusted
by adding it as a covariate in the regression model for the outcome
analysis [28].
Supporting Information Appendix S6 provides the weighted
difference-in-difference estimates of hospitalizations for each of
the three treatment levels and non-participants as well as
Bonferroni adjusted contrasts between each level versus non-
participants. Taken together, both the non-treatment group and the
single call per year group showed a decrease in pre-post admis-
sions, but the difference between them was not statistically sig-
nificant (P-value = 0.75). Contrary to expectations, both the 2–3
calls per year group and 4+ calls per year group increased their
pre-post admissions to a greater extent than non-participants.
Application of MMWS to
nominal treatments
In some health care studies, patients are assigned to one of several
independent (nominal) interventions. For example, a drug study
may be implemented to compare the efficacy of competing drugs,
or a health management program may utilize different modes of
communication with patients to determine which approach results
in the highest level of patient self-management.
In the nominal treatment framework, no treatment group is
considered higher in ranking order than any other (except when
compared with the control group) and all treatment groups are
expected to be comparable on baseline characteristics. In the out-
comes analysis of nominal treatments, all groups serve as
counterfactuals to all others with a series of post-estimation con-
trasts conducted to determine which intervention was the most
effective.
Table 2 Calculation of the marginal mean weights through stratification (MMWS) for an ordinal treatment within common support
Stratum
Non-participants
(nz=0,s)
MMWS
(no calls)
1 Call
(nz=1,s)
MMWS
(one call)
2–3 Calls
(nz=2,s)
MMWS
(2–3 calls)
4 + Calls
(nz=3,s)
MMWS
(4 + calls) ns
1 1181 1.048 77 0.873 62 0.616 46 0.500 1366
2 1210 1.022 72 0.933 53 0.721 30 0.766 1365
3 1235 1.002 78 0.862 29 1.318 24 0.959 1366
4 1281 0.965 51 1.317 25 1.528 8 2.874 1365
5 1278 0.968 58 1.158 22 1.736 7 3.285 1365
Total 6185 336 191 115 6827
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For the purpose of illustrating the MMWS technique for
nominal treatments, the current sample was divided according to
treatment assignment: (1) 6612 non-participants; (2) 654 partici-
pants in the telephonic intervention; and (3) 705 participants in the
RTM intervention. Supporting Information Appendix S7 presents
the unadjusted pre-intervention characteristics of participants in
the three study arms. As shown, groups were statistically different
from each other in 6 of the 11 covariates.
For an intervention with nominal treatments, propensity scores
are estimated using multinomial logistic regression [26]. Using
this approach, each individual receives one propensity score cor-
responding to the probability of assignment to each treatment,
conditional on baseline characteristics. Thus, in the current data,
three propensity scores were estimated for each individual corre-
sponding to their probability of assignment to non-participation,
the telephonic intervention and RTM, respectively.
The region of common support was determined by ensuring that
each individual’s three propensity scores were within the common
bounds of all three propensity score ranges. Individuals outside of
this common region were flagged and received an MMWS weight
of zero. In the current data, a total of 104 individuals were flagged
as being outside the common region of support, leaving 7867
individuals remaining in the analytic sample.
Next, each of the three propensity scores for everyone in the
analytic sample was stratified into five approximately equal-sized
quintiles of 1573 individuals per stratum. Thus, there were three
propensity score strata (corresponding to the three propensity
scores) divided into five quintiles each (see Table 3). The marginal
mean weights for the nominal case were computed based on the
formula by Hong [22]:
n Z z
n
s
z z s
z
z
× =
=
Pr( )
,
(2)
where nsz is the total number of individuals in a given stratum sz
for a corresponding propensity score θz, Pr(Z = z) is the probability
of assignment to a given treatment group z, and nz z sz= , is the total
number of individuals in stratum sz that were actually assigned to
treatment z. Table 3 displays all the necessary values used in com-
puting the MMWS for each stratum and group assignment in the
nominal treatment case. Taking the RTM group in stratum 1 as an
example, we replace Equation 2 with the numeric equivalents:
1547 702
7867
33
4 256
× ⎛⎝ )
= .
Similarly, the MMWS weights for the telephonic intervention in
stratum 1 are calculated as follows:
1574 649
7867
78
1 665
× ⎛⎝ )
= .
After weights were calculated for each treatment group by stratum,
each individual in the dataset received the weight corresponding to
their stratum and their actual treatment assignment.
Supporting Information Appendix S8 presents the baseline
characteristics of participants in the three arms of the study,
adjusted with the MMWS weights. As shown, with the exception
of hospital days, all covariates in the weighted data have P-values
that are substantially higher than the traditional 0.05 cut-off. The
residual imbalance of hospital days is further adjusted by adding it
as a covariate in the regression model for the outcome analysis.
Supporting Information Appendix S9 provides the weighted
difference-in-difference estimates of hospitalizations for the three
study arms, as well as Bonferroni adjusted contrasts between each
arm and the other two arms. Both the non-treatment group and the
RTM group showed a comparable decrease in pre-post admissions
of −0.30 admission per person, while the telephonic intervention
had a much lesser decrease of –0.15 admission per person. The
contrasts indicate that there was no statistical difference between
RTM versus non-participants, or RTM versus the telephonic inter-
vention. However, the telephonic intervention group did statisti-
cally worse than the non-treatment group (0.15 admission per
person, 95% CI 0.019, 0.278).
Discussion
The purpose of this paper was to introduce readers to MMWS, a
recent addition to the family of propensity score-based techniques.
The analytic approach was described in detail for three of the most
typical types of experimental designs (the binary treatment,
ordinal treatments and nominal treatments) using data from a DM
intervention.
Because of its flexibility and wide application, MMWS may
hold greater appeal for program evaluators compared with existing
approaches, most of which are constrained by the specific study
design implemented. For example, while the entire array of pro-
pensity scoring techniques (described in the Introduction) can be
used to evaluate binary treatments, only weighting approaches can
be seriously considered for evaluating interventions with multiple
levels or multiple arms [3]. While this does not pose a limitation in
evaluating health care interventions per se, an attractive quality of
MMWS is the ability to conduct several types of evaluations of the
same intervention using a consistent overall approach (as demon-
strated by our examples). Moreover, the MMWS approach can be
Table 3 Calculation of the marginal mean
weights through stratification (MMWS) for
multiple (nominal) treatments within
common support
Stratum
Non-participants Telephonic RTM
ns0 nz = 0,s0 MMWS ns1 nz = 1,s1 MMWS ns2 nz = 2,s2 MMWS
1 1574 1128 1.156 1574 78 1.665 1574 33 4.256
2 1573 1219 1.069 1573 105 1.236 1573 82 1.712
3 1574 1340 0.973 1574 126 1.031 1574 116 1.211
4 1573 1371 0.950 1573 158 0.821 1573 178 0.789
5 1573 1458 0.894 1573 182 0.713 1573 293 0.479
Total 7867 6516 7867 649 7867 702
RTM, remote tele-monitoring.
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extended to accommodate multiple concurrent treatments, handle
multilevel data and assess the effects of moderated treatments
[21,22]. A somewhat similar approach has also been proposed to
analyse treatment effects in longitudinal data [29].
Beyond its flexibility, MMWS has also been shown to be more
accurate compared with IPTW in estimating outcomes. Huang
et al. [20] used both techniques and found that the IPTW results
were much more variable, and in many cases did not agree with
the other two methods applied to the data (the stratification
approach and hierarchical outcome regression). Similarly, Hong
[21] found through a comprehensive set of simulations that
MMWS had much lower bias and higher accuracy (lower mean
square errors) than IPTW when the propensity score model was
misspecified (which is the case with most data used in health
care interventions).
While MMWS may be more appealing than other propensity
scoring approaches for evaluating health care interventions using
non-experimental data, it still carries the same limitation as all
other models for causal inference; that is, it assumes that all biases
and sources of confounding have been adjusted for in the model –
an assumption that cannot be tested outside of a randomized study.
Thus, regardless of the specific technique employed, the evalu-
ation is best served by conducting sensitivity analyses to determine
the magnitude of unmeasured bias necessary to alter the conclu-
sion that observed outcomes reflect the effect of the intervention
[30].
In summary, this paper describes an alternative propensity
score-based adjustment procedure that combines stratification and
weighting to allow for the estimation of treatment effects. Because
of its flexibility and wide application, MMWS should be consid-
ered as an alternative procedure for use with observational data
when evaluating the effectiveness of health care interventions.
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